Theorem Clinical Research

United States

PharmAthene awarded $28.1M to develop thermostable anthrax vaccine

Thursday, September 11, 2014 01:36 PM

PharmAthene, an Annapolis, Md.-based biodefense company developing medical countermeasures against biological and chemical threats, has announced the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, has awarded the company a contract, valued at up to $28.1 million if all contract options are exercised, for the development of a next-generation anthrax vaccine based on the company's proprietary rPA anthrax vaccine technology platform.

More... »


PMG Research forms its 11th clinical site

Wednesday, September 10, 2014 03:07 PM

PMG Research (PMG), an integrated network of clinical research facilities in the southeastern U.S., has established its 11th clinical research site, PMG Research of Rocky Mount. PMG Research has assumed ownership and operation of the clinical research department at Boice-Willis Clinic in Rocky Mount, N.C., further expanding PMG’s presence in eastern North Carolina. This new site enhances PMG’s access to an additional 130,000 patients.

More... »


Survey reveals knowledge gaps among Parkinson's patients and caregivers

Wednesday, September 10, 2014 03:04 PM

Information and specialized care can help patients become more engaged in their own treatment and in the Parkinson's disease (PD) community, according to a recent online survey of more than 1,500 PD patients, caregivers and physicians conducted by Harris Poll on behalf of the Michael J. Fox Foundation and AbbVie.

More... »

Report: clinical trials will continue to play a key role in oncology device market

Wednesday, September 10, 2014 03:03 PM

The U.S. interventional oncology device market will see strong growth, reaching a value of $760 million by 2023, according to Decision Resources Group. Rising cancer incidence rates, combined with the ineffectiveness of chemotherapy and demand for less invasive procedures, will support interventional oncology device uptake.

More... »

Livongo Health launched

Wednesday, September 10, 2014 03:00 PM

Livongo Health, a California-based consumer digital health company, has launched with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information and support from a chosen care team.

More... »

Oregon associations Oregon Bio and TAO collaborate

Monday, September 8, 2014 01:54 PM

Oregon Bioscience Association (Oregon Bio), a nonprofit member association based in Oregon, and the Technology Association of Oregon (TAO) are collaborating to cultivate Oregon's health information technologies, personal digital health products, bioinformatics and health analytics industries. Both organizations will coordinate support for companies, entrepreneurs, research institutes and care organizations to expand Oregon's life sciences and digital health economy.

More... »

AMRI's expands discovery biology offerings

Monday, September 8, 2014 01:52 PM

Albany Molecular Research (AMRI), a New York-based global CRO, has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of about 4.1% to about $9.2 billion by 2018.

More... »

DrugDev named Best Place to Work by the Philadelphia Business Journal

Friday, September 5, 2014 10:12 AM

The Philadelphia Business Journal has named DrugDev one of its Best Places to Work in the Philadelphia region. The recognition continues the tradition established by CFS Clinical, a provider of global investigator payment, contracting and regulatory services, which had been named to the prestigious list each of the previous two years until it was acquired by DrugDev in October 2013.

More... »

Debiopharm Group's antibiotic Debio 1450 receives QIDP designation from the FDA

Friday, September 5, 2014 09:40 AM

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, has announced that the FDA has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

More... »

Johnson & Johnson to accelerate Ebola vaccine program in collaboration with NIH

Thursday, September 4, 2014 12:29 PM

Johnson & Johnson has committed to accelerate its Ebola vaccine program in collaboration with the NIH. J&J will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate to deliver immediate relief aid to address the current Ebola outbreak.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private ἀnancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs